A Strategic Manufacturing Partner
for Complex Drug Products

About Emergent Bioservices

We are the Bioservices (CDMO) division of Emergent BioSolutions, a global company providing solutions that address public health threats. With 25 years of experience developing, manufacturing, and delivering our own portfolio of therapeutic and vaccine products, we offer biotech and pharma companies a strategic and reliable manufacturing solution for their complex drug products. 

We have the scientific and regulatory compliance experience, development and manufacturing resources, and efficient technology transfer capabilities that can harness the urgency, acuity, and scalability required to bring life-saving products to market.

Our Commitment

Even when the world changes around us and new challenges emerge, our mission stays the same — to improve and protect the health of billions of people around the globe by supporting innovative drug makers that make the seemingly impossible possible. Read more about how our commitments to supporting regulatory and quality assurance excellence help our biopharma clients deliver their life-saving and life-extending products to patients worldwide.

What We Do

Emergent Bioservices stands ready to put our resources, capabilities, capacity and expertise to work for you.


Process Development, Optimization & Scale up

Our development services team has extensive experience in process development, optimization and scale up, and offer a broad range of analytical development services to help our clients overcome challenges with their products. Whether your program is in clinical or commercial phases, our development services are primed to plug in right where you need them.


Plasma Icon - white

Plasma Protein Manufacturing

Emergent's Winnipeg, MB, Canada site has decades of experience in the production, purification, filling, and packaging of commercial plasma-derived products.  We are uniquely positioned to support biopharma companies in bringing plasma-derived therapies from development through tech transfer to commercialization.



Aseptic Fill/Finish Services

Our drug product manufacturing capabilities are designed to support all phases of your product lifecycle. With state-of-the-art Annex 1 compliant isolator filling lines designed for high value clinical and commercial products, and integrated packaging and labeling solutions, Emergent has the technology and expertise to support your growth and scale-up, now and in the future.


 ico-mic-carmine In the News

Outsourced Pharma Capacity Update | July 2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live...

Read More

A Strategic and Collaborative Partner 

Global health risks. Rare disease therapeutics. Novel medicines.  No matter where your innovation is centered, you'll find us a like-minded and more-than-capable manufacturing partner. We maintain a holistic perspective as we help you accelerate along your drug development and manufacturing pathway.

Why Partner With Us

The Power of the
Emergent Way

“The Emergent Way” is visible in everything we do for you. The elements that define it aren’t labeled that way, of course, but you’ll see the hallmarks of what make us different at every turn.

Flexible & Scalable Technologies
Efficient Tech Transfer
Agility and Reliability
Passion for the Vision
Partnership Thinking
Entrepreneurial Spirit

Let’s Start A Conversation

Connect now